- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01452841
A Grapefruit Feeding Trial in Healthy, Overweight Adults
Efficiency of Daily Grapefruit Exposure in Reducing Body Weight and Inflammatory Markers
Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, though there is some evidence of health promotional effects regarding blood pressure and lipid profiles. The aims of this randomized controlled trial are to determine the role of grapefruit in:
- Reducing weight
- Reducing blood pressure
- Reducing inflammation
- Improving the lipid profile.
The investigators hypothesize that six weeks of daily consumption of grapefruit will reduce weight, blood pressure, and inflammation while improving the lipid profile in overweight, healthy adults.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults, men and premenopausal women
- BMI: 25-45 kg/m2
- Willing to maintain current exercise regimen (not to exceed 10 hours/week)
- Willing to follow a diet low in bioactive rich fruits and vegetables and with no citrus
Exclusion Criteria:
- History of chronic disease
- Metabolic disease
- Inflammatory disease
- High cholesterol (>225 mg/dL)
- Smoker
- Taking medications metabolized by the Cytochrome P450 3A enzyme
- History of alcohol or drug abuse
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control
|
Participants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks
|
|
Experimental: Grapefruit Consumption
|
1.5 Rio Red Grapefruit consumed daily for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight reduction
Time Frame: 6 weeks
|
Participants consumed 1/2 grapefruit before each meal (1.5 grapefruit per day) for six weeks.
Weight was measured before and after grapefruit consumption to assess weight change.
Weight change was considered statistically significant at p<0.05.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure reduction
Time Frame: 6 weeks
|
Previous studies in animals and humans consuming citrus have resulted in reductions in blood pressure, though no direct effect of grapefruit has ever been demonstrated.
Blood pressure was measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).
|
6 weeks
|
|
Lipid Profile Improvements
Time Frame: 6 weeks
|
Previous studies in humans and animal models consuming grapefruit or grapefruit bioactives have shown reductions in triglycerides, LDL, and total cholesterol and increases in circulating HDL.
These parameters were measured via a common point-of-care system, LDX Cholestech.
Lipids were measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).
|
6 weeks
|
|
Reductions in markers of chronic inflammation
Time Frame: 6 weeks
|
Markers of chronic inflammation, which are also associated with endothelial dysfunction and heart disease, like tumor necrosis factor alpha (TNFalpha), interleukin-1beta (IL-1beta), and soluble vascular cellular adhesion molecule-1 (sV-CAM1) were measured.
Inflammatory markers were measured at baseline and after the 6 week intervention period (consuming either the control diet or supplementing the diet with 1/2 grapefruit before each meal).
|
6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Cynthia Thomson, PhD, RD, University of Arizona
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-0695-02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Grapefruit
-
Vanderbilt UniversityCompleted
-
Johnson & Johnson Consumer and Personal Products...Completed
-
University of FloridaCompletedPharmacokineticsUnited States
-
Nemours Children's ClinicMerck Sharp & Dohme LLCCompleted
-
Children's Hospital of PhiladelphiaWithdrawn
-
University Hospital, Clermont-FerrandFRANCE; UMR 1019 Unité de Nutrition Humaine; INRA de Clermont-Fd / Theix; Equipe... and other collaboratorsCompletedPost-menopausal StatusFrance
-
USDA, Western Human Nutrition Research CenterCompletedBioavailability of CarotenoidsUnited States
-
Haukeland University HospitalCompleted
-
Shirley M. TsunodaCompletedKidney Transplant; Complications | Drug Interaction FoodUnited States